Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 152 Pages
Report ld: 3499543
Request Sample
Customized Report
The global market for COVID-19 Diagnostic Kits was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Coronavirus disease 2019 (COVID-19) is an infectious acute respiratory disease caused by a novel coronavirus. There are different types of COVID-19 tests - diagnostic tests and antibody tests. COVID-19 testing includes molecular testing, antigen testing, and antibody testing. Samples for COVID-19 diagnostic tests are usually collected using an anterior nasal (nose) swab sample. Some diagnostic tests use a sample of the middle turbinate, nasopharynx, oropharynx, or saliva.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for COVID-19 Diagnostic Kits, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of COVID-19 Diagnostic Kits by region & country, by Type, and by Application.
The COVID-19 Diagnostic Kits market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 Diagnostic Kits.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of COVID-19 Diagnostic Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of COVID-19 Diagnostic Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of COVID-19 Diagnostic Kits in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 COVID-19 Diagnostic Kits Product Introduction
1.2 Global COVID-19 Diagnostic Kits Market Size Forecast
1.2.1 Global COVID-19 Diagnostic Kits Sales Value (2020-2031)
1.2.2 Global COVID-19 Diagnostic Kits Sales Volume (2020-2031)
1.2.3 Global COVID-19 Diagnostic Kits Sales Price (2020-2031)
1.3 COVID-19 Diagnostic Kits Market Trends & Drivers
1.3.1 COVID-19 Diagnostic Kits Industry Trends
1.3.2 COVID-19 Diagnostic Kits Market Drivers & Opportunity
1.3.3 COVID-19 Diagnostic Kits Market Challenges
1.3.4 COVID-19 Diagnostic Kits Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global COVID-19 Diagnostic Kits Players Revenue Ranking (2024)
2.2 Global COVID-19 Diagnostic Kits Revenue by Company (2020-2025)
2.3 Global COVID-19 Diagnostic Kits Players Sales Volume Ranking (2024)
2.4 Global COVID-19 Diagnostic Kits Sales Volume by Company Players (2020-2025)
2.5 Global COVID-19 Diagnostic Kits Average Price by Company (2020-2025)
2.6 Key Manufacturers COVID-19 Diagnostic Kits Manufacturing Base and Headquarters
2.7 Key Manufacturers COVID-19 Diagnostic Kits Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of COVID-19 Diagnostic Kits
2.9 COVID-19 Diagnostic Kits Market Competitive Analysis
2.9.1 COVID-19 Diagnostic Kits Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by COVID-19 Diagnostic Kits Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Diagnostic Kits as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Molecular Detection
3.1.2 Antigen Detection
3.1.3 Antibody Detection
3.2 Global COVID-19 Diagnostic Kits Sales Value by Type
3.2.1 Global COVID-19 Diagnostic Kits Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global COVID-19 Diagnostic Kits Sales Value, by Type (2020-2031)
3.2.3 Global COVID-19 Diagnostic Kits Sales Value, by Type (%) (2020-2031)
3.3 Global COVID-19 Diagnostic Kits Sales Volume by Type
3.3.1 Global COVID-19 Diagnostic Kits Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global COVID-19 Diagnostic Kits Sales Volume, by Type (2020-2031)
3.3.3 Global COVID-19 Diagnostic Kits Sales Volume, by Type (%) (2020-2031)
3.4 Global COVID-19 Diagnostic Kits Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Laboratory
4.1.3 Home
4.2 Global COVID-19 Diagnostic Kits Sales Value by Application
4.2.1 Global COVID-19 Diagnostic Kits Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global COVID-19 Diagnostic Kits Sales Value, by Application (2020-2031)
4.2.3 Global COVID-19 Diagnostic Kits Sales Value, by Application (%) (2020-2031)
4.3 Global COVID-19 Diagnostic Kits Sales Volume by Application
4.3.1 Global COVID-19 Diagnostic Kits Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global COVID-19 Diagnostic Kits Sales Volume, by Application (2020-2031)
4.3.3 Global COVID-19 Diagnostic Kits Sales Volume, by Application (%) (2020-2031)
4.4 Global COVID-19 Diagnostic Kits Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global COVID-19 Diagnostic Kits Sales Value by Region
5.1.1 Global COVID-19 Diagnostic Kits Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global COVID-19 Diagnostic Kits Sales Value by Region (2020-2025)
5.1.3 Global COVID-19 Diagnostic Kits Sales Value by Region (2026-2031)
5.1.4 Global COVID-19 Diagnostic Kits Sales Value by Region (%), (2020-2031)
5.2 Global COVID-19 Diagnostic Kits Sales Volume by Region
5.2.1 Global COVID-19 Diagnostic Kits Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global COVID-19 Diagnostic Kits Sales Volume by Region (2020-2025)
5.2.3 Global COVID-19 Diagnostic Kits Sales Volume by Region (2026-2031)
5.2.4 Global COVID-19 Diagnostic Kits Sales Volume by Region (%), (2020-2031)
5.3 Global COVID-19 Diagnostic Kits Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America COVID-19 Diagnostic Kits Sales Value, 2020-2031
5.4.2 North America COVID-19 Diagnostic Kits Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe COVID-19 Diagnostic Kits Sales Value, 2020-2031
5.5.2 Europe COVID-19 Diagnostic Kits Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific COVID-19 Diagnostic Kits Sales Value, 2020-2031
5.6.2 Asia Pacific COVID-19 Diagnostic Kits Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America COVID-19 Diagnostic Kits Sales Value, 2020-2031
5.7.2 South America COVID-19 Diagnostic Kits Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa COVID-19 Diagnostic Kits Sales Value, 2020-2031
5.8.2 Middle East & Africa COVID-19 Diagnostic Kits Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions COVID-19 Diagnostic Kits Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions COVID-19 Diagnostic Kits Sales Value
6.2.1 Key Countries/Regions COVID-19 Diagnostic Kits Sales Value, 2020-2031
6.2.2 Key Countries/Regions COVID-19 Diagnostic Kits Sales Volume, 2020-2031
6.3 United States
6.3.1 United States COVID-19 Diagnostic Kits Sales Value, 2020-2031
6.3.2 United States COVID-19 Diagnostic Kits Sales Value by Type (%), 2024 VS 2031
6.3.3 United States COVID-19 Diagnostic Kits Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe COVID-19 Diagnostic Kits Sales Value, 2020-2031
6.4.2 Europe COVID-19 Diagnostic Kits Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe COVID-19 Diagnostic Kits Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China COVID-19 Diagnostic Kits Sales Value, 2020-2031
6.5.2 China COVID-19 Diagnostic Kits Sales Value by Type (%), 2024 VS 2031
6.5.3 China COVID-19 Diagnostic Kits Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan COVID-19 Diagnostic Kits Sales Value, 2020-2031
6.6.2 Japan COVID-19 Diagnostic Kits Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan COVID-19 Diagnostic Kits Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea COVID-19 Diagnostic Kits Sales Value, 2020-2031
6.7.2 South Korea COVID-19 Diagnostic Kits Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea COVID-19 Diagnostic Kits Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia COVID-19 Diagnostic Kits Sales Value, 2020-2031
6.8.2 Southeast Asia COVID-19 Diagnostic Kits Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia COVID-19 Diagnostic Kits Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India COVID-19 Diagnostic Kits Sales Value, 2020-2031
6.9.2 India COVID-19 Diagnostic Kits Sales Value by Type (%), 2024 VS 2031
6.9.3 India COVID-19 Diagnostic Kits Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Information
7.1.2 Abbott Introduction and Business Overview
7.1.3 Abbott COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Abbott COVID-19 Diagnostic Kits Product Offerings
7.1.5 Abbott Recent Development
7.2 Access Bio
7.2.1 Access Bio Company Information
7.2.2 Access Bio Introduction and Business Overview
7.2.3 Access Bio COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Access Bio COVID-19 Diagnostic Kits Product Offerings
7.2.5 Access Bio Recent Development
7.3 ACON Laboratories
7.3.1 ACON Laboratories Company Information
7.3.2 ACON Laboratories Introduction and Business Overview
7.3.3 ACON Laboratories COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 ACON Laboratories COVID-19 Diagnostic Kits Product Offerings
7.3.5 ACON Laboratories Recent Development
7.4 Alveo Technologies
7.4.1 Alveo Technologies Company Information
7.4.2 Alveo Technologies Introduction and Business Overview
7.4.3 Alveo Technologies COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Alveo Technologies COVID-19 Diagnostic Kits Product Offerings
7.4.5 Alveo Technologies Recent Development
7.5 Applied BioCode
7.5.1 Applied BioCode Company Information
7.5.2 Applied BioCode Introduction and Business Overview
7.5.3 Applied BioCode COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Applied BioCode COVID-19 Diagnostic Kits Product Offerings
7.5.5 Applied BioCode Recent Development
7.6 ARISTA Biotech
7.6.1 ARISTA Biotech Company Information
7.6.2 ARISTA Biotech Introduction and Business Overview
7.6.3 ARISTA Biotech COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 ARISTA Biotech COVID-19 Diagnostic Kits Product Offerings
7.6.5 ARISTA Biotech Recent Development
7.7 BD
7.7.1 BD Company Information
7.7.2 BD Introduction and Business Overview
7.7.3 BD COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 BD COVID-19 Diagnostic Kits Product Offerings
7.7.5 BD Recent Development
7.8 Biocartis
7.8.1 Biocartis Company Information
7.8.2 Biocartis Introduction and Business Overview
7.8.3 Biocartis COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Biocartis COVID-19 Diagnostic Kits Product Offerings
7.8.5 Biocartis Recent Development
7.9 BioFire Diagnostics
7.9.1 BioFire Diagnostics Company Information
7.9.2 BioFire Diagnostics Introduction and Business Overview
7.9.3 BioFire Diagnostics COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 BioFire Diagnostics COVID-19 Diagnostic Kits Product Offerings
7.9.5 BioFire Diagnostics Recent Development
7.10 BioMedomics
7.10.1 BioMedomics Company Information
7.10.2 BioMedomics Introduction and Business Overview
7.10.3 BioMedomics COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 BioMedomics COVID-19 Diagnostic Kits Product Offerings
7.10.5 BioMedomics Recent Development
7.11 Cepheid
7.11.1 Cepheid Company Information
7.11.2 Cepheid Introduction and Business Overview
7.11.3 Cepheid COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Cepheid COVID-19 Diagnostic Kits Product Offerings
7.11.5 Cepheid Recent Development
7.12 Co-Diagnostics
7.12.1 Co-Diagnostics Company Information
7.12.2 Co-Diagnostics Introduction and Business Overview
7.12.3 Co-Diagnostics COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Co-Diagnostics COVID-19 Diagnostic Kits Product Offerings
7.12.5 Co-Diagnostics Recent Development
7.13 Cue Health
7.13.1 Cue Health Company Information
7.13.2 Cue Health Introduction and Business Overview
7.13.3 Cue Health COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Cue Health COVID-19 Diagnostic Kits Product Offerings
7.13.5 Cue Health Recent Development
7.14 Diasorin
7.14.1 Diasorin Company Information
7.14.2 Diasorin Introduction and Business Overview
7.14.3 Diasorin COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Diasorin COVID-19 Diagnostic Kits Product Offerings
7.14.5 Diasorin Recent Development
7.15 Ellume
7.15.1 Ellume Company Information
7.15.2 Ellume Introduction and Business Overview
7.15.3 Ellume COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Ellume COVID-19 Diagnostic Kits Product Offerings
7.15.5 Ellume Recent Development
7.16 Grifols
7.16.1 Grifols Company Information
7.16.2 Grifols Introduction and Business Overview
7.16.3 Grifols COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Grifols COVID-19 Diagnostic Kits Product Offerings
7.16.5 Grifols Recent Development
7.17 Hologic
7.17.1 Hologic Company Information
7.17.2 Hologic Introduction and Business Overview
7.17.3 Hologic COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Hologic COVID-19 Diagnostic Kits Product Offerings
7.17.5 Hologic Recent Development
7.18 Andon Health
7.18.1 Andon Health Company Information
7.18.2 Andon Health Introduction and Business Overview
7.18.3 Andon Health COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Andon Health COVID-19 Diagnostic Kits Product Offerings
7.18.5 Andon Health Recent Development
7.19 Lepu Medical
7.19.1 Lepu Medical Company Information
7.19.2 Lepu Medical Introduction and Business Overview
7.19.3 Lepu Medical COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Lepu Medical COVID-19 Diagnostic Kits Product Offerings
7.19.5 Lepu Medical Recent Development
7.20 Lucira Health
7.20.1 Lucira Health Company Information
7.20.2 Lucira Health Introduction and Business Overview
7.20.3 Lucira Health COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.20.4 Lucira Health COVID-19 Diagnostic Kits Product Offerings
7.20.5 Lucira Health Recent Development
7.21 Orient Gene
7.21.1 Orient Gene Company Information
7.21.2 Orient Gene Introduction and Business Overview
7.21.3 Orient Gene COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.21.4 Orient Gene COVID-19 Diagnostic Kits Product Offerings
7.21.5 Orient Gene Recent Development
7.22 Quidel
7.22.1 Quidel Company Information
7.22.2 Quidel Introduction and Business Overview
7.22.3 Quidel COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.22.4 Quidel COVID-19 Diagnostic Kits Product Offerings
7.22.5 Quidel Recent Development
7.23 Roche
7.23.1 Roche Company Information
7.23.2 Roche Introduction and Business Overview
7.23.3 Roche COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.23.4 Roche COVID-19 Diagnostic Kits Product Offerings
7.23.5 Roche Recent Development
7.24 Shenzhen YHLO Biotech
7.24.1 Shenzhen YHLO Biotech Company Information
7.24.2 Shenzhen YHLO Biotech Introduction and Business Overview
7.24.3 Shenzhen YHLO Biotech COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.24.4 Shenzhen YHLO Biotech COVID-19 Diagnostic Kits Product Offerings
7.24.5 Shenzhen YHLO Biotech Recent Development
7.25 Guangzhou Wondfo Biotech
7.25.1 Guangzhou Wondfo Biotech Company Information
7.25.2 Guangzhou Wondfo Biotech Introduction and Business Overview
7.25.3 Guangzhou Wondfo Biotech COVID-19 Diagnostic Kits Sales, Revenue, Price and Gross Margin (2020-2025)
7.25.4 Guangzhou Wondfo Biotech COVID-19 Diagnostic Kits Product Offerings
7.25.5 Guangzhou Wondfo Biotech Recent Development
8 Industry Chain Analysis
8.1 COVID-19 Diagnostic Kits Industrial Chain
8.2 COVID-19 Diagnostic Kits Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 COVID-19 Diagnostic Kits Sales Model
8.5.2 Sales Channel
8.5.3 COVID-19 Diagnostic Kits Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for COVID-19 Diagnostic Kits was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 158
USD 3950.00
(Single User License)
The global COVID-19 Diagnostic Kits market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 147
USD 2900.00
(Single User License)
The global COVID-19 Diagnostic Kits market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 112
USD 4250.00
(Single User License)
The global COVID-19 Diagnostic Kits market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 197
USD 4900.00
(Single User License)
The global market for COVID-19 Diagnostic Kits was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 115
USD 2900.00
(Single User License)
Coronavirus disease 2019 (COVID-19) is an infectious acute respiratory disease caused by a novel coronavirus. There are different types of COVID-19 tests - diagnostic tests and antibody tests. COVID-19 testing includes molecular testing, antigen testing, and antibody testing. Samples for COVID-19 diagnostic tests are usually collected using an anterior nasal (nose) swab sample. Some diagnostic tests use a sample of the middle turbinate, nasopharynx, oropharynx, or saliva.
Published Date: 2024-04-28
Pages: 128
USD 4900.00
(Single User License)
Coronavirus disease 2019 (COVID-19) is an infectious acute respiratory disease caused by a novel coronavirus. There are different types of COVID-19 tests - diagnostic tests and antibody tests. COVID-19 testing includes molecular testing, antigen testing, and antibody testing. Samples for COVID-19 diagnostic tests are usually collected using an anterior nasal (nose) swab sample. Some diagnostic tests use a sample of the middle turbinate, nasopharynx, oropharynx, or saliva.
Published Date: 2024-01-18
Pages: 116
USD 2900.00
(Single User License)
The global market for COVID-19 Diagnostic Kits was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 158
The global COVID-19 Diagnostic Kits market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 147
The global COVID-19 Diagnostic Kits market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 112
The global COVID-19 Diagnostic Kits market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 197
The global market for COVID-19 Diagnostic Kits was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 115
Coronavirus disease 2019 (COVID-19) is an infectious acute respiratory disease caused by a novel coronavirus. There are different types of COVID-19 tests - diagnostic tests and antibody tests. COVID-19 testing includes molecular testing, antigen testing, and antibody testing. Samples for COVID-19 diagnostic tests are usually collected using an anterior nasal (nose) swab sample. Some diagnostic tests use a sample of the middle turbinate, nasopharynx, oropharynx, or saliva.
Published: 2024-04-28
Pages: 128
Coronavirus disease 2019 (COVID-19) is an infectious acute respiratory disease caused by a novel coronavirus. There are different types of COVID-19 tests - diagnostic tests and antibody tests. COVID-19 testing includes molecular testing, antigen testing, and antibody testing. Samples for COVID-19 diagnostic tests are usually collected using an anterior nasal (nose) swab sample. Some diagnostic tests use a sample of the middle turbinate, nasopharynx, oropharynx, or saliva.
Published: 2024-01-18
Pages: 116
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now